Willie Quinn
Chief Executive Officer (Incoming)
Replay available
Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call
Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Q1 2024 earnings conference call, held 2024-05-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Edith Perez
Chief Medical Officer (Outgoing)
Randy Schatzman
Chief Executive Officer (Outgoing)
Dawn Colburn
Senior Vice President of Clinical Development
Michael Alonso
Senior Vice President of Research & Co-Founder
Jeffrey La Rosa
Analyst, Learing Partners
Steven Willie
Analyst, Stiefel
Michael Schmidt
Analyst, Guggenheim
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Bolt Biotherapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.131 Good afternoon, and welcome to the BOLT Biotherapeutics Strategic Update Conference Call. 00:00:05.131 -- 00:00:08.212 At this time, all participants are in listen-only mode. 00:00:08.212 -- 00:00:11.794 After the speaker's presentation, we will conduct a question and answer session. 00:00:11.794 -- 00:00:15.995 Instructions will be given at that time. As a reminder, this call may be recorded. 00:00:15.995 -- 00:00:21.117 I would like to hand the call over to Willie Quinn, incoming Chief Executive Officer 00:00:21.117 -- 00:00:23.958 of BOLT Biotherapeutics. 00:00:23.958 -- 00:00:26.159 Please go ahead, sir. 00:00:26.159 -- 00:00:30.166 Thank you, and good afternoon, everyone. This afternoon, we issued our first quarter 00:00:30.166 -- 00:00:35.217 2024 financial results and business update, which outlines the topics 00:00:35.217 -- 00:00:40.118 we plan to discuss today. You can access the press release by going to the investors 00:00:40.118 -- 00:00:44.619 and media section of our website at www.boltbio.com. 00:00:45.959 -- 00:00:50.960 I am joined today by Randy Schatzman, outgoing chief executive officer, and 00:00:50.960 -- 00:00:54.321 Edith Perez, outgoing chief medical officer. 00:00:54.321 -- 00:00:59.443 I am also joined by some newly promoted members of BOLT's senior leadership team, including 00:00:59.443 -- 00:01:05.386 Michael Alonso, co-founder of BOLT and newly promoted senior vice president of research, 00:01:05.386 -- 00:01:10.769 and Don Colburn, newly promoted senior vice president of clinical development. 00:01:10.769 -- 00:01:15.111 Before we begin, I'd like to remind everyone that during this call, we will be making 00:01:15.111 -- 00:01:19.573 forward-looking statements that are subject to a number of risks a...